CSIMarket
 


Adma Biologics Inc   (ADMA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

ADMA's Operating Income Growth by Quarter and Year

Adma Biologics Inc 's Operating Income results by quarter and year




ADMA Operating Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -7.83 -16.55 -10.54
III Quarter September - -9.05 -13.79 -14.43
II Quarter June - -11.34 -13.42 -8.40
I Quarter March -16.77 -13.21 -16.53 -5.94
FY   -16.77 -41.43 -60.29 -39.31



ADMA Operating Income first quarter 2020 Y/Y Growth Comment
Adma Biologics Inc in the first quarter recorded Operating Loss of $ -16.77 millions.

According to the results reported in the first quarter, Adma Biologics Inc achieved the best Operating Income growth in Biotechnology & Drugs industry. While Adma Biologics Inc ' s Operating Income no change of % ranks overall at the positon no. in the first quarter.

Explain Operating Income growth


ADMA Operating Income ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Adma Biologics Inc 's first quarter 2020 Operating Income $ -16.77 millions ADMA's Income Statement
Adma Biologics Inc 's first quarter 2019 Operating Income $ -13.21 millions Quarterly ADMA's Income Statement
New: More ADMA's historic Operating Income Growth >>


ADMA Operating Income (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Adma Biologics Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ADMA's I. Quarter Q/Q Operating Income Comment
Recent results of -16.77 millions by Adma Biologics Inc look even less good considering the Operating Loss -7.83 millions a quarter before.

Within Biotechnology & Drugs industry Adma Biologics Inc achieved highest sequential Operating Income growth. While Adma Biologics Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ADMA's I. Quarter Q/Q Operating Income Comment
I. Quarter 2020 Operating Loss of -16.77 millions by Adma Biologics Inc come out even worse if you take a look at -7.83 millions Operating Loss in the forth quarter.

Within Biotechnology & Drugs industry Adma Biologics Inc achieved highest sequential Operating Income growth. While Adma Biologics Inc 's Operating Income growth quarter on quarter, overall rank is .


Adma Biologics Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
Cumulative Operating Income 12 Months Ending $ -44.99 $ -41.42 $ -50.15 $ -54.89 $ -56.96
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment


Adma Biologics Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


Adma Biologics Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Drugs Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
ADMA's Operating Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for ADMA's Competitors
Operating Income Growth for Adma Biologics Inc 's Suppliers
Operating Income Growth for ADMA's Customers

You may also want to know
ADMA's Annual Growth Rates ADMA's Profitability Ratios ADMA's Asset Turnover Ratio ADMA's Dividend Growth
ADMA's Roe ADMA's Valuation Ratios ADMA's Financial Strength Ratios ADMA's Dividend Payout Ratio
ADMA's Roa ADMA's Inventory Turnover Ratio ADMA's Growth Rates ADMA's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Mar 31 2020
Innoviva inc   45.90 %$ 45.904 millions
Teva Pharmaceutical Industries Ltd  42.54 %$ 42.537 millions
Nuvasive Inc  40.38 %$ 40.381 millions
Resmed Inc   38.56 %$ 38.555 millions
Medpace Holdings inc   37.11 %$ 37.108 millions
Charles River Laboratories International inc   35.09 %$ 35.089 millions
Alexion Pharmaceuticals Inc   34.58 %$ 34.578 millions
Johnson and Johnson  31.46 %$ 31.456 millions
Bio rad Laboratories Inc   31.39 %$ 31.387 millions
Edwards Lifesciences Corporation  30.60 %$ 30.598 millions
Anika Therapeutics Inc   29.41 %$ 29.405 millions
Zoetis Inc   25.30 %$ 25.296 millions
West Pharmaceutical Services Inc   24.47 %$ 24.470 millions
China Health Industries Holdings Inc   23.94 %$ 23.944 millions
Standard Diversified Inc   23.64 %$ 23.641 millions
Biogen Inc   21.11 %$ 21.109 millions
Stryker Corp  20.27 %$ 20.265 millions
Merck and Co Inc   20.09 %$ 20.092 millions
Meridian Bioscience Inc  19.89 %$ 19.888 millions
Abbvie Inc   19.70 %$ 19.701 millions
Select Medical Holdings Corp  15.17 %$ 15.175 millions
Supernus Pharmaceuticals inc   14.09 %$ 14.095 millions
Millendo Therapeutics Inc   13.87 %$ 13.869 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CLIR's Profile

Stock Price

CLIR's Financials

Business Description

Fundamentals

Charts & Quotes

CLIR's News

Suppliers

CLIR's Competitors

Customers & Markets

Economic Indicators

CLIR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright Š 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071